Manner Carrie Eglinton Quest Diagnostics Inc (DGX) insider trading activity

Manner Carrie Eglinton is SVP, Advanced Diagnostics of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 48,391 shares of DGX, which is worth approximately $6.63 Million. The most recent transaction as insider was on Mar 07, 2022, when has been sold 7,947 shares (Common Stock) at a price of $130.09 per share, resulting in proceeds of $1,033,825. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K

0% 3M change

0% 12M change

Total Value Held $6.63 Million

MANNER CARRIE EGLINTON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2022	SELL Payment of exercise price or tax liability	$1,033,825 $130.09 p/Share	7,947 Reduced 14.11%	48,391 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	$2,102,515 $130.09 p/Share	16,162 Added 22.29%	56,338 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	11,745 Added 22.62%	40,176 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$257,326 $130.16 p/Share	1,977 Reduced 6.5%	28,431 Common Stock
Mar 09 2021	SELL Payment of exercise price or tax liability	$711,564 $115.42 p/Share	6,165 Reduced 16.93%	30,250 Common Stock
Mar 09 2021	BUY Grant, award, or other acquisition	$1,521,351 $115.42 p/Share	13,181 Added 26.59%	36,394 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$74,047 $121.19 p/Share	611 Reduced 2.56%	23,213 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$123,210 $121.15 p/Share	1,017 Reduced 4.09%	23,824 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	4,926 Added 16.55%	24,841 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$314,160 $119.0 p/Share	2,640 Reduced 11.71%	19,896 Common Stock

Also insider at

RGEN

REPLIGEN CORP Healthcare

OSUR

ORASURE TECHNOLOGIES INC Healthcare

President & CEO

MCE